In summary, our studies suggest that Hydralazine ameliorates experimental renal fibrosis through inducing de-methylation of aberrantly methylated Rasal1 (and additional genes as well) by Dnmt1 inhibition and by inducing the endogenous Tet3/Tdg de-methylation pathway. Here, DNMT1 is linked to renal fibrosis.